Pfizer Nears Deal to Combine off-Patent Drug Business With Mylan

  • 📰 WSJ
  • ⏱ Reading Time:
  • 52 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 24%
  • Publisher: 63%

Deutschland Nachrichten Nachrichten

Deutschland Neuesten Nachrichten,Deutschland Schlagzeilen

Pfizer is in talks to merge its off-patent drugs business with Mylan, creating a global giant in lower-priced medicines, people familiar say

By Jonathan D. Rockoff and Cara Lombardo July 27, 2019 7:59 am ET Pfizer Inc. PFE 0.98% is in talks to merge its off-patent drugs business with generic drugmaker Mylan NV, according to people familiar with the matter, in a deal that would create a giant global seller of lower-priced medicines.

Current Mylan Chief Executive Heather Bresch would depart, the person said. The combined company would be based in the U.S. The squeeze has hurt the sales—and shares—of Mylan and other leading generic drugmakers, notably Teva Pharmaceutical Industries Ltd. Mylan stock has dropped by about 75% from its high in the spring of 2015.

Both Pfizer and Mylan, which is incorporated in the Netherlands but run from Pittsburgh, had been seeking ways to bolster their slowing businesses. In May, Mr. Bourla broached the idea of a combination with Mr. Coury, one of the people familiar with the deal said. But their sales have been declining since generic rivals hit the market, weighing on the company as it seeks to rev up growth by launching new branded drugs and vaccines for cancer, heart disease and other conditions.

Mylan’s board, meantime, has been conducting a strategic review as the company tries to revive sales by moving into more complex—and higher-priced—generics and copies of biotech drugs.

 

Vielen Dank für Ihren Kommentar.Ihr Kommentar wird nach Prüfung veröffentlicht.

Otherwise known as drug pushing.

Pull the other one. RIPGOP Pfizer, killing people by the thousands daily.

“lowered priced medicines” 😐 Bullshit pfizer

Lol yes... price always goes down with less competition...

Imagine trying to spin monopolies as a good thing

Shush

Wierd, lol

These companies have so much money they don’t need to merge to offer lower price medicine. They just need to not be dicks and offer lower price medicines.

Watch as US prices for off-patent drugs rise. Now that US regs are gone (thanks GOP), it's open season on seniors & those who are ill. Pfizer is not doing this to help lower costs. Got my doc to give me alternatives to 2 Pfizer on-patent meds because they support Fox News.

A lower priced giant that controls all the costs?

Genericseditor !

jonathanrockoff so that they can raise the price?

Ha ha ha. Lower prices. Ha ha ha. Methinks I've heard that before. Ha ha ha.

Sr. lopez atención sr. lopez..... Se necesitán medicamentos en méxico... Atención

Wir haben diese Nachrichten zusammengefasst, damit Sie sie schnell lesen können. Wenn Sie sich für die Nachrichten interessieren, können Sie den vollständigen Text hier lesen. Weiterlesen:

 /  🏆 98. in DE

Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen

Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.

Apple is buying the majority of Intel's smartphone modem business in a $1 billion dealApple is acquiring the majority of Intel's smartphone modem business in a deal valued at $1 billion. No stop NOooooooooOooOoOoOOooOOO Hmmm These corporate mfkers never stop. Phew!
Herkunft: BusinessInsider - 🏆 729. / 51 Weiterlesen »